Jon Stonehouse
Chief Executive Officer chez BIOCRYST PHARMACEUTICALS, INC.
Fortune : 6 M $ au 31/03/2024
Profil
Jon P.
Stonehouse's current job(s) include being the President, Chief Executive Officer & Director at BioCryst Pharmaceuticals, Inc. and the Director at The North Carolina Museum of Life & Science, Inc. Mr. Stonehouse's former job(s) include being the Chairman at Bellicum Pharmaceuticals, Inc. from 2022 to 2024.
He also worked as a Director at AstraZeneca PLC, Precision BioSciences, Inc., Astra Merck, Inc., Merck & Co., Inc., Merck KGaA, and EMD Pharmaceuticals, Inc.Mr. Stonehouse completed his undergraduate degree at the University of Minnesota.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 03/01/2024 | 1 134 770 ( 0,55% ) | 6 M $ | 31/03/2024 |
Postes actifs de Jon Stonehouse
| Sociétés | Poste | Début |
|---|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Chief Executive Officer | 01/01/2007 |
The North Carolina Museum of Life & Science, Inc.
 The North Carolina Museum of Life & Science, Inc. Other Consumer ServicesConsumer Services The North Carolina Museum of Life & Science, Inc. operates museums and exhibitions. The company was founded in 1946 and is headquartered in Durham, NC. | Director/Board Member | - |
Anciens postes connus de Jon Stonehouse
| Sociétés | Poste | Fin |
|---|---|---|
| BELLICUM PHARMACEUTICALS, INC. | Chairman | 23/02/2024 |
| MERCK KGAA | Corporate Officer/Principal | 01/12/2006 |
| PRECISION BIOSCIENCES, INC. | Director/Board Member | - |
| MERCK & CO., INC. | Sales & Marketing | - |
| ASTRAZENECA PLC | Sales & Marketing | - |
Formation de Jon Stonehouse
| University of Minnesota | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Health Technology |
| MERCK & CO., INC. | Health Technology |
| ASTRAZENECA PLC | Health Technology |
| MERCK KGAA | Health Technology |
| PRECISION BIOSCIENCES, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Bellicum Pharmaceuticals, Inc.
 Bellicum Pharmaceuticals, Inc. BiotechnologyHealth Technology Bellicum Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It focuses on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders. The firm uses its proprietary chemical induction of dimerization that controls components of the immune system in real time. Its product candidates include BPX-601, BPX-603, and Rivo-cel (rivogenlecleucel, formerly known as BPX-501). The company was founded by Kevin M. Slawin and David M. Spencer on July 14, 2004 and is headquartered in Houston, TX. | Health Technology |
Astra Merck, Inc.
 Astra Merck, Inc. Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, Astra Merck, Inc. is a private company that sells pharmaceutical products. The company is based in Orlando, FL. The company was founded by Myrtle S. Potter, Thomas A. McCourt. Astra Merck was acquired by Astra AB from Merck & Co., Inc. on July 12, 1998 for $4,400 million. | Health Technology |
EMD Pharmaceuticals, Inc.
 EMD Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Merck KGaA, EMD Pharmaceuticals, Inc. is a private company that manufactures pharmaceutical preparations. The company is based in Durham, NC. The company was founded by Nancy J. Wysenski. | Health Technology |
The North Carolina Museum of Life & Science, Inc.
The North Carolina Museum of Life & Science, Inc. Other Consumer ServicesConsumer Services The North Carolina Museum of Life & Science, Inc. operates museums and exhibitions. The company was founded in 1946 and is headquartered in Durham, NC. | Consumer Services |
